Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 132

1.

Hypofractionation vs conventional radiation therapy for newly diagnosed diffuse intrinsic pontine glioma: a matched-cohort analysis.

Janssens GO, Jansen MH, Lauwers SJ, Nowak PJ, Oldenburger FR, Bouffet E, Saran F, Kamphuis-van Ulzen K, van Lindert EJ, Schieving JH, Boterberg T, Kaspers GJ, Span PN, Kaanders JH, Gidding CE, Hargrave D.

Int J Radiat Oncol Biol Phys. 2013 Feb 1;85(2):315-20. doi: 10.1016/j.ijrobp.2012.04.006. Epub 2012 Jun 9.

PMID:
22682807
2.

Incidence and virulence determinants of verocytotoxin-producing Escherichia coli infections in the Brussels-Capital Region, Belgium, in 2008-2010.

Buvens G, De Gheldre Y, Dediste A, de Moreau AI, Mascart G, Simon A, Allemeersch D, Scheutz F, Lauwers S, Piérard D.

J Clin Microbiol. 2012 Apr;50(4):1336-45. doi: 10.1128/JCM.05317-11. Epub 2012 Jan 11.

3.

Expectancy bias in a selective conditioning procedure: trait anxiety increases the threat value of a blocked stimulus.

Boddez Y, Vervliet B, Baeyens F, Lauwers S, Hermans D, Beckers T.

J Behav Ther Exp Psychiatry. 2012 Jun;43(2):832-7. doi: 10.1016/j.jbtep.2011.11.005. Epub 2011 Dec 13.

PMID:
22197754
4.

Acceptance criteria for identification results of Gram-negative rods by mass spectrometry.

De Bel A, Wybo I, Vandoorslaer K, Rosseel P, Lauwers S, Piérard D.

J Med Microbiol. 2011 May;60(Pt 5):684-6. doi: 10.1099/jmm.0.023184-0. Epub 2011 Jan 13. No abstract available.

PMID:
21233293
5.

Virulence profiling and quantification of verocytotoxin-producing Escherichia coli O145:H28 and O26:H11 isolated during an ice cream-related hemolytic uremic syndrome outbreak.

Buvens G, Possé B, De Schrijver K, De Zutter L, Lauwers S, Piérard D.

Foodborne Pathog Dis. 2011 Mar;8(3):421-6. doi: 10.1089/fpd.2010.0693. Epub 2010 Dec 18.

PMID:
21166561
6.

Antimicrobial resistance testing of verocytotoxin-producing Escherichia coli and first description of TEM-52 extended-spectrum β-lactamase in serogroup O26.

Buvens G, Bogaerts P, Glupczynski Y, Lauwers S, Piérard D.

Antimicrob Agents Chemother. 2010 Nov;54(11):4907-9. doi: 10.1128/AAC.00551-10. Epub 2010 Aug 23.

7.

Prevalence of subtilase cytotoxin in verocytotoxin-producing Escherichia coli isolated from humans and raw meats in Belgium.

Buvens G, Lauwers S, Piérard D.

Eur J Clin Microbiol Infect Dis. 2010 Nov;29(11):1395-9. doi: 10.1007/s10096-010-1014-z. Epub 2010 Aug 3.

PMID:
20680367
8.

Correct implementation of matrix-assisted laser desorption ionization-time of flight mass spectrometry in routine clinical microbiology.

De Bel A, Wybo I, Piérard D, Lauwers S.

J Clin Microbiol. 2010 May;48(5):1991; author reply 1991-2. doi: 10.1128/JCM.00403-10. No abstract available.

9.

Correction of underquantification of human immunodeficiency virus type 1 load with the second version of the Roche Cobas AmpliPrep/Cobas TaqMan assay.

De Bel A, Marissens D, Debaisieux L, Liesnard C, Van den Wijngaert S, Lauwers S, Piérard D.

J Clin Microbiol. 2010 Apr;48(4):1337-42. doi: 10.1128/JCM.01226-09. Epub 2010 Feb 17.

10.

First sorbitol-fermenting Verocytotoxin-producing Escherichia coli O157: H- isolated in Belgium.

Buvens G, Piérard D, Hachimi-Idrissi S, Lauwers S.

Acta Clin Belg. 2009 Jan-Feb;64(1):59-64.

PMID:
19317243
11.

Microbiology of bile in cholelithiasis patients with and without acute pancreatitis.

De Waele B, Delvaux G, Lauwers S.

Pancreas. 2009 Jan;38(1):102-3. doi: 10.1097/MPA.0b013e31816909ba. No abstract available.

PMID:
19106748
12.

Outbreak of multidrug-resistant Acinetobacter baumannii in a Belgian university hospital after transfer of patients from Greece.

Wybo I, Blommaert L, De Beer T, Soetens O, De Regt J, Lacor P, Piérard D, Lauwers S.

J Hosp Infect. 2007 Dec;67(4):374-80. Epub 2007 Nov 19.

PMID:
18023922
13.

Characterization of Bordetella pertussis clinical isolates that do not express the tracheal colonization factor.

van Gent M, Pierard D, Lauwers S, van der Heide HG, King AJ, Mooi FR.

FEMS Immunol Med Microbiol. 2007 Oct;51(1):149-54.

14.

Third Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria.

Wybo I, Piérard D, Verschraegen I, Reynders M, Vandoorslaer K, Claeys G, Delmée M, Glupczynski Y, Gordts B, Ieven M, Melin P, Struelens M, Verhaegen J, Lauwers S.

J Antimicrob Chemother. 2007 Jan;59(1):132-9. Epub 2006 Nov 9.

15.
16.

Biologically active bisbenzylisoquinoline alkaloids from the root bark of Epinetrum villosum.

Otshudi AL, Apers S, Pieters L, Claeys M, Pannecouque C, De Clercq E, Van Zeebroeck A, Lauwers S, Frédérich M, Foriers A.

J Ethnopharmacol. 2005 Oct 31;102(1):89-94.

PMID:
15996841
17.

External quality assessment for molecular detection of Bordetella pertussis in European laboratories.

Muyldermans G, Soetens O, Antoine M, Bruisten S, Vincart B, Doucet-Populaire F, Fry NK, Olcén P, Scheftel JM, Senterre JM, van der Zee A, Riffelmann M, Piérard D, Lauwers S.

J Clin Microbiol. 2005 Jan;43(1):30-5.

18.

Salmonella enterica subspecies houtenae serotype 44:z4, z23:--as a rare cause of meningitis.

Wybo I, Potters D, Plaskie K, Covens L, Collard JM, Lauwers S.

Acta Clin Belg. 2004 Jul-Aug;59(4):232-4.

PMID:
15597733
19.

[Screening for Staphylococcus aureus with a reduced susceptibility to vancomycin in: a Belgian hospital].

Piérard D, Vandenbussche H, Verschraegen I, Lauwers S.

Pathol Biol (Paris). 2004 Oct;52(8):486-8. French.

PMID:
15465269
20.

Isolation of Arcobacter skirrowii from a patient with chronic diarrhea.

Wybo I, Breynaert J, Lauwers S, Lindenburg F, Houf K.

J Clin Microbiol. 2004 Apr;42(4):1851-2. No abstract available.

21.

Simple Algorithm for Identification of Bordetella pertussis Pertactin Gene Variants.

Muyldermans G, Piérard D, Hoebrekx N, Advani R, Van Amersfoorth S, De Schutter I, Soetens O, Eeckhout L, Malfroot A, Lauwers S.

J Clin Microbiol. 2004 Apr;42(4):1614-9.

22.

Biliary tract infection in patients with acute biliary pancreatitis.

De Waele B, Van Nieuwenhove Y, Lauwers S, Delvaux G.

Surg Infect (Larchmt). 2003 Fall;4(3):241-6.

PMID:
14588158
23.

In vitro activity of ertapenem against anaerobes isolated from the respiratory tract.

Piérard D, Wybo I, Vandoorslaer K, Roebben E, Rosseel P, Lauwers S.

Pathol Biol (Paris). 2003 Oct;51(8-9):508-11.

PMID:
14568599
25.

Prevalence of fragilysin gene in Bacteroides fragilis isolates from blood and other extraintestinal samples.

Foulon I, Piérard D, Muyldermans G, Vandoorslaer K, Soetens O, Rosseel P, Lauwers S.

J Clin Microbiol. 2003 Sep;41(9):4428-30.

26.

Molecular typing of Bordetella pertussis isolates recovered from Belgian children and their household members.

De Schutter I, Malfroot A, Dab I, Hoebrekx N, Muyldermans G, Piérard D, Lauwers S.

Clin Infect Dis. 2003 Jun 1;36(11):1391-6. Epub 2003 May 21.

PMID:
12766833
27.

Recovery of Mycobacterium elephantis from sputum of a patient in Belgium.

Potters D, Seghers M, Muyldermans G, Piérard D, Naessens A, Lauwers S.

J Clin Microbiol. 2003 Mar;41(3):1344. No abstract available.

28.

Pan-European study on culture-proven Legionnaires' disease: distribution of Legionella pneumophila serogroups and monoclonal subgroups.

Helbig JH, Bernander S, Castellani Pastoris M, Etienne J, Gaia V, Lauwers S, Lindsay D, Lück PC, Marques T, Mentula S, Peeters MF, Pelaz C, Struelens M, Uldum SA, Wewalka G, Harrison TG.

Eur J Clin Microbiol Infect Dis. 2002 Oct;21(10):710-6. Epub 2002 Oct 18.

PMID:
12415469
29.
30.

Enteric infections due to Escherichia coli.

Piérard D, Lauwers S.

Clin Microbiol Infect. 1998 Jul;4(7):414-415. No abstract available.

31.

Hemolytic uremic syndrome in Belgium: incidence and association with verocytotoxin-producing Escherichia coli infection.

Cornu G, Proesmans W, Dediste A, Jacobs F, Van De Walle J, Mertens A, Ramet J, Lauwers S.

Clin Microbiol Infect. 1999 Jan;5(1):16-22.

32.

Comparison of two methods for serotyping Ureaplasma urealyticum clinical isolates.

Echahidi F, van Geel K, Lauwers S, Naessens A.

J Microbiol Methods. 2002 Apr;49(2):157-61.

PMID:
11830301
34.

Blinded, multicenter quality control study for the quantification of human immunodeficiency virus type 1 RNA in plasma by the Belgian AIDS reference laboratories.

Muyldermans G, Debaisieux L, Fransen K, Marissens D, Miller K, Vaira D, Vandamme AM, Vandenbroucke AT, Verhofstede C, Schuurman R, Zissis G, Lauwers S.

Clin Microbiol Infect. 2000 Apr;6(4):213-7.

35.

Development of an enzyme-linked immunosorbent assay for serotyping ureaplasma urealyticum strains using monoclonal antibodies.

Echahidi F, Muyldermans G, Lauwers S, Naessens A.

Clin Diagn Lab Immunol. 2001 Jan;8(1):52-7.

36.

Outbreak of necrotizing enterocolitis associated with Enterobacter sakazakii in powdered milk formula.

van Acker J, de Smet F, Muyldermans G, Bougatef A, Naessens A, Lauwers S.

J Clin Microbiol. 2001 Jan;39(1):293-7.

37.

Development of monoclonal antibodies against Ureaplasma urealyticum serotypes and their use for serotyping clinical isolates.

Echahidi F, Muyldermans G, Lauwers S, Naessens A.

Clin Diagn Lab Immunol. 2000 Jul;7(4):563-7.

38.

In vitro antimicrobial activity of six medicinal plants traditionally used for the treatment of dysentery and diarrhoea in Democratic Republic of Congo (DRC).

Otshudi AL, Foriers A, Vercruysse A, Van Zeebroeck A, Lauwers S.

Phytomedicine. 2000 Apr;7(2):167-72.

PMID:
10839221
39.

The clinical impact of early gram-positive bacteremia and the use of vancomycin after allogeneic bone marrow transplantation.

Schots R, Trullemans F, Van Riet I, Kaufman L, Hafsia A, Meddeb B, Hadj Ali ZB, Ben Abid H, Lauwers S, Van Camp B.

Transplantation. 2000 Apr 15;69(7):1511-4.

PMID:
10798782
40.

In vitro susceptibility of Enterococcus faecium isolated from food to growth-promoting and therapeutic antibiotics.

Butaye P, Van Damme K, Devriese LA, Van Damme L, Bael M, Lauwers S, Haesebrouck F.

Int J Food Microbiol. 2000 Mar 25;54(3):181-7.

PMID:
10777068
41.

The influence of alcohol disinfection of nail samples in the laboratory.

Willemsen R, Breynaert J, Lauwers S.

Mycoses. 1999;42(11-12):645-7.

PMID:
10680441
42.

A case-control study of sporadic infection with O157 and non-O157 verocytotoxin-producing Escherichia coli.

Piérard D, Crowcroft N, De Bock S, Potters D, Crabbe G, Van Loock F, Lauwers S.

Epidemiol Infect. 1999 Jun;122(3):359-65.

43.

Surgical site infections.

Lauwers S, de Smet F.

Acta Clin Belg. 1998 Oct;53(5):303-10. Review.

PMID:
9861754
44.

Identification of new verocytotoxin type 2 variant B-subunit genes in human and animal Escherichia coli isolates.

Piérard D, Muyldermans G, Moriau L, Stevens D, Lauwers S.

J Clin Microbiol. 1998 Nov;36(11):3317-22.

45.

Neonatal infections with Pseudomonas aeruginosa associated with a water-bath used to thaw fresh frozen plasma.

Muyldermans G, de Smet F, Pierard D, Steenssens L, Stevens D, Bougatef A, Lauwers S.

J Hosp Infect. 1998 Aug;39(4):309-14.

PMID:
9749402
46.
47.
48.

Development of a monoclonal antibody to a Ureaplasma urealyticum serotype 9 antigen.

Naessens A, Cheng X, Lauwers S, Robertson JA.

J Clin Microbiol. 1998 Apr;36(4):1125-7.

49.

Extensive outbreak of food-borne illness in Hasselt: was it Escherichia coli O157:H7?

Piérard D, Forier A, Bogaerts-Vandebeek I, Van Pelt H, Stevens D, Lauwers S.

Acta Clin Belg. 1998 Feb;53(1):57-8. No abstract available.

PMID:
9562709
50.

Surgical prophylaxis in Belgian hospitals: estimate of costs and potential savings.

Sasse A, Mertens R, Sion JP, Ronveaux O, Bossens M, De Mol P, Goossens H, Lauwers S, Potvliege C, Van Landuyt H, Verbist L, Verschraegen G.

J Antimicrob Chemother. 1998 Feb;41(2):267-72.

PMID:
9533470

Supplemental Content

Loading ...
Support Center